Optometrists in Dartmouth, MA Accepting Medicare

9 Optometrists found. Showing 1 - 9

Dr. Joel D Altman, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 325 State Rd, Mass Optometric Associates, P.c., Dartmouth, MA 02747 Phone: 508-996-3364    Fax: 508-994-7451

Ashley Elise Sousa, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 51 State Rd, Dartmouth, MA 02747 Phone: 508-994-1400    Fax: 508-910-2204

Optometric Providers Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 325 State Line Rd, Rte 6, Dartmouth, MA 02747 Phone: 508-996-3364    Fax: 508-994-7451

Matthew Brillon, OD Optometrist Medicare: Medicare Enrolled Practice Location: 500 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-717-0270

Mass Optometric Associates, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 325 State Rd, Route 6, Dartmouth, MA 02747 Phone: 508-996-3364    Fax: 508-994-7451

Dr. Jason Brett Pick, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 325 State Rd, Mass Optometric Associates, P.c., Dartmouth, MA 02747 Phone: 508-996-3364    Fax: 508-994-7451

Optomeyes Health Pc Optometrist Medicare: Medicare Enrolled Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-207-3569

Eye Health Associates Inc Optometrist Medicare: Medicare Enrolled Practice Location: 51 State Road, Dartmouth, MA 02747 Phone: 508-994-1400    Fax: 508-910-2212

Breanna Catherine Marques, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 51 State Rd, Dartmouth, MA 02747 Phone: 508-500-6900

News Archive

Ocugen's OCU100 gets FDA orphan drug designation for treatment of retinitis pigmentosa

Ocugen, Inc. and the University of Colorado today announced exclusive license agreements that allow for Ocugen to continue developing two drug candidates for the treatment for ophthalmology indications, and that one of the assets, OCU100, recombinant lens epithelium derived growth factor 1-326 (LEDGF1-326), received orphan-drug status from the U.S. Food and Drug Administration for treatment of retinitis pigmentosa (RP), a rare eye disease.

First medical center to alleviate snoring issues

Sereno™, The Center for Snoring Solutions, opened its doors to patients this month at its flagship practice in San Francisco. Sereno is the first medical center of its kind dedicated solely to resolving snoring issues by providing patients with a comprehensive, solutions-based approach.

Nanobody works against all SARS-CoV-2 variants of concern in animal model

Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.

Delinquency in children now linked to biology

How do sweet children turn into delinquents seemingly right before our eyes. A unique study appearing in the June issue of Psychological Science, a journal of the Association for Psychological Science, shows that, in children, a highly reactive autonomic nervous system, which regulates our cardiovascular, digestive and respiratory functions, paired with a stressful family environment leads to increased instances of maladaptive personality change.

Measles found on children travelling from China

Public Health officials have reported a laboratory-confirmed case of measles in a recently adopted child from China. Public health authorities in Washington state notified CDC, which collaborated with health officials in other states to locate other recently adopted children from China and contact their adoptive families.

Read more Medical News

› Verified 3 days ago